Meeting
2019 ASCO Annual Meeting
Genomic biomarkers of recurrence in low-grade, early-stage endometrial adenocarcinoma.
Authors
Katie Lee Hwang
Harvard Radiation Oncology Program, Boston, MA
Katie Lee Hwang , William L. Hwang , Brooke E. Howitt , Martin T. King , Elizabeth Stover , Ursula A. Matulonis , Larissa Janeen Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 5588)
DOI
10.1200/JCO.2019.37.15_suppl.5588
Abstract #
5588
Poster Bd #
411
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Identifying biomarkers associated with disease-free survival in stage I non–small cell lung cancer.
First Author: Christopher W. Seder
Poster
2019 ASCO Annual Meeting
A plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay to inform recurrence risk in colorectal cancer (CRC).
First Author: Aparna Raj Parikh
Poster
2018 ASCO Annual Meeting
Preoperative olaparib in early-stage endometrial cancer (EC): A phase 0, window of opportunity trial to evaluate the PARP inhibition effect, targeting cell cycle-related proteins (POLEN study).
First Author: Ignacio Romero
Poster
2016 ASCO Annual Meeting
Use of next-generation sequencing (NGS) panels to predict recurrence in low-grade, early-stage endometrioid endometrial carcinoma.
First Author: Katherine Kurnit